ALK-Abello, Nelco Laboratories deal

ALK-Abello disclosed in its 2Q10 earnings that it acquired Nelco's allergy and vaccination operations for DKK16 million ($2.7 million) in cash. ALK-Abello said the deal gives it access to Nelco's dist...